Medtronic Stock-Based Compensation — Historical Data
Medtronic (MDT) stock-based compensation was $457M in FY2026 (+7% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2026
$457M
+7%
2025
$429M
+9%
2024
$393M
+11%
2023
$355M
-1%
2022
$359M
+4%
2021
$344M
+16%
2020
$297M
+2%
2019
$290M
-16%
2018
$344M
-1%
2017
$348M
-7%
2016
$375M
-15%
2015
$439M
+203%
2014
$145M
-5%
2013
$152M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q2 2026
$125M
Q1 2026
$95M
Q3 2025
$182M
Q2 2025
$86M
Q1 2025
$89M
Q3 2024
$159M
Q2 2024
$83M
Q1 2024
$90M
Q3 2023
$146M
Q2 2023
$73M
Q1 2023
$75M
Q3 2022
$137M
Source: MDT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.